Sumitomo Mitsui Trust Group
FOLD

Sumitomo Mitsui Trust Group’s Amicus Therapeutics FOLD Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,070
Closed -$203K – 1099
2026
Q1 		$203K Sell
14,070
-780
-5% -$11.2K ﹤0.01% 1034
2025
Q4 		$211K Buy
14,850
+2,700
+22% +$26.5K ﹤0.01% 1036
2025
Q3 		$95.7K Buy
12,150
+900
+8% +$6.41K ﹤0.01% 1050
2025
Q2 		$64.5K Buy
+11,250
New +$72.6K ﹤0.01% 1032

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sumitomo Mitsui Trust Group's FOLD Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 14,070 shares — an estimated $203K sold.

Sumitomo Mitsui Trust Group first reported a position in FOLD in Q2 2025 and held it in 4 quarters. The position peaked at $211K in Q4 2025. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

  • Sumitomo Mitsui Trust Group reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 14,070 Amicus Therapeutics shares in Q2 2026, an estimated $203K.
  • Sumitomo Mitsui Trust Group first reported a position in Amicus Therapeutics in Q2 2025 and held it in 4 quarters.
  • Sumitomo Mitsui Trust Group's Amicus Therapeutics position peaked at $211K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.